Apr 15,2020

Yes Health closes $6 million Series A to expand digital health platform

Yes Health, a leading digital health provider focused on weight loss, nutrition counseling and preventing type 2 diabetes, today announced $6 million in new Series A funding led by Khosla Ventures.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 21,2020

Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy

Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor (“CGM”), today announced it has secured a 24-month, $5 million non-convertible loan.

FUNDING POST-IPO EQUITY

#cgm

View Analyst & Ambassador Comments
Go to original news
May 27,2020

Babylon Health leads a $30M Series B in US health kiosk operator, Higi

UK-based AI chatbot Babylon Health — which last year raised $550M at a $2BN+ valuation — has led a $30M Series B in US-based Higi, which owns and operates 10,000+ FDA-cleared health kiosks. Higi kiosks have been used by 62M people in North America to date, conducting more than 372M biometric tests. Babylon’s investment in the company will go on supporting the expansion and “enhancement” of this network and it will broaden company's clinical capabilities and ability to support consumers with acute medical problems or those with chronic conditions like hypertension, diabetes, and obesity, thereby allowing Higi to better meet the needs of payors, retailers and health systems.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 27,2020

Siren raises $11.8M for its limb-saving smart socks

Siren, a company that’s building smart, washable fabric wearables — the first of which is a pair of socks meant to help those with diabetes monitor their foot health and detect dangerous injuries early.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 28,2020

PercuSense Awarded $4.6M DIU/DTRA Contract to Develop Continuous Biosensor System for Early Detection of Toxic Chemical Exposure

PercuSense, Inc., an intelligent biosensor and digital health company dedicated to improving healthcare through the use of multi-analyte sensor systems to predict and prevent disease progression, today announced it has been awarded funding from the Defense Threat Reduction Agency (DTRA) and the Defense Innovation Unit (DIU) to develop a continuous monitoring platform for early detection of toxic chemical exposure.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jun 02,2020

Bigfoot Biomedical® Announces Close of its $55M Series C Round

Bigfoot Biomedical, Inc. announced today that the company has raised a total of $55 million to close its Series C equity financing. The round was led by Abbott with support from existing investors, including Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management, along with new investors including Smile Group.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jun 12,2020

Medtronic Announces a $337 Million Product Investment from Blackstone Life Sciences to Expand Development of Future Diabetes Technologies

Medtronic plc (NYSE:MDT) and Blackstone (NYSE:BX) today announced that Medtronic intends to significantly increase research and development (R&D) funding in its Diabetes Group through an agreement to receive $337 million of funding from funds managed by Blackstone Life Sciences (“BXLS”) including co-investors, aimed at advancing new, innovative products especially designed to reduce the burden of diabetes management.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Jul 09,2020

GlySens Incorporated Closes Incremental $15 Million Financing Supporting On-Going Clinical Evaluations

GlySens Incorporated announced that the company has closed on an incremental $15M financing. The round was led by previous lead investors, McNair Interests and The Sarofim Group. Proceeds from the financing will support ongoing clinical trials and development programs supporting the Company’s fully implanted, long-term CGM systems and additionally, enable first-in-man studies of the third-generation system.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Jul 27,2020

Indigo Diabetes concludes a €38 million round of financing

Indigo Diabetes nv, a young high-tech medical device company that develops medical solutions using nanophotonics, today announced the conclusion of a €38 million Series B funding round to further develop its promising Multi-Biomarker Sensor for people with diabetes.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 31,2020

DarioHealth Announces $28.6 Million Private Placement

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel. The company received aggregate gross proceeds of approximately $28.6 million, before deducting placement agent fees and other offering expenses.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING